EUVIMEDEUVIMED entdecken
Kohortenstudie

Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real‐world cohort study in Catalonia, Spain

Marina Fuente-Moreno iD, Caitriona Cahir iD, Valéria Lima Passos, Kathleen Bennett, Caroline Walsh, Patricia Hermida-González, Jorge Peláez de Loño, Maria Eugènia Rey Abella, Luisa Baladon, Maria Rubio-Valera, Antoni Serrano-Blanco, Ignacio Aznar-Lou

British Journal of Clinical Pharmacology · 2025-06 · 91 (6) · 1790-1801

DOI: 10.1111/bcp.16399 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 09.02.2025. Verfasst von Marina Fuente-Moreno und 11 weiteren Autor:innen. Beteiligte Einrichtung: Health Technology Assessment in Primary Care and Mental Health (PRISMA), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain. Hauptthemen laut MEDLINE: Antipsychotic Agents, Medication Adherence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Suboptimal adherence to antipsychotics leads to poorer outcomes and relapse. Several factors, including the formulation and number of antipsychotics, may influence medication adherence. This study aimed to identify longitudinal adherence patterns to oral and long‐acting injectable (LAI) antipsychotics in monotherapy/polypharmacy through group‐based trajectory modelling (GBTM).

Methods

This was a retrospective cohort study that linked prescription and dispensing data of adult patients with a new antipsychotic prescribed between 2015 and 2019 in Catalonia (Spain). GBTM was used to classify patients following a similar longitudinal pattern of adherence. The response variable was adherence, estimated through the continuous medication availability measure (CMA), in each 30‐day period during 12 months of follow‐up. Baseline and treatment characteristics were used to characterize the trajectories identified.

Results

Among the 7730 patients included in the study, we identified seven clinically distinct trajectory groups of adherence to antipsychotics: non‐initiation (19%), low implementation (9%), immediate discontinuation (6%), mid‐discontinuation (5%), late‐discontinuation (5%), high implementation (21%), and full implementation (35%). Trajectories with better adherence were more likely to receive the prescription from a psychiatrist, receive LAIs and have previous exposure to other antipsychotics. Intermittent medication use and high levels of polypharmacy were characteristics of the “low” and “high implementation” groups.

Conclusions

Targeting newly prescribed patients by improving the clinician–patient relationship could be particularly valuable, as they seem more likely to not initiate or discontinue treatment immediately compared to patients in other groups. Patients on polypharmacy should have more regular adherence monitoring and LAIs should be considered, as they appear to be associated with better adherence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsMedication AdherenceHumansSpainRetrospective StudiesMaleFemaleMiddle AgedAdultPolypharmacyAgedAdministration, OralDelayed-Action PreparationsLongitudinal Studies

Stichwörter der Autor:innen

antipsychotic medicationgroup‐based trajectory modellingmedication adherencemental healthreal‐world data

Substanzen

Antipsychotic AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Health Technology Assessment in Primary Care and Mental Health (PRISMA), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
  • Facultat de Medicina I Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain.
  • Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
  • School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland.
  • Discipline of Pharmacology & Therapeutics, School of Medicine, Trinity College Dublin, Ireland.

ORCID-Profile: Marina Fuente-Moreno, Caitriona Cahir

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Fuente-Moreno, M., Cahir, C., Passos, V. L., Bennett, K., Walsh, C., Hermida-González, P., Peláez de Loño, J., Abella, M. E. R., Baladon, L., Rubio-Valera, M., Serrano-Blanco, A., & Aznar-Lou, I. (2025). Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real‐world cohort study in Catalonia, Spain. British Journal of Clinical Pharmacology, 91(6), 1790-1801. https://doi.org/10.1111/bcp.16399

Vancouver

Fuente-Moreno M, Cahir C, Passos VL, Bennett K, Walsh C, Hermida-González P, et al. Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real‐world cohort study in Catalonia, Spain. British Journal of Clinical Pharmacology. 2025;91(6):1790-1801. doi:10.1111/bcp.16399

BibTeX
@article{FuenteMoreno2025,
  author = {Fuente-Moreno, Marina and Cahir, Caitriona and Passos, Valéria Lima and Bennett, Kathleen and Walsh, Caroline and Hermida-González, Patricia and Peláez de Loño, Jorge and Abella, Maria Eugènia Rey and Baladon, Luisa and Rubio-Valera, Maria and Serrano-Blanco, Antoni and Aznar-Lou, Ignacio},
  title = {Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real‐world cohort study in Catalonia, Spain},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {6},
  pages = {1790--1801},
  doi = {10.1111/bcp.16399}
}
Kostenlos starten →